Peter Greenleaf
President and CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Executive Officer | $822,877 | $5,858,590 |
| 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | $822,877 | $6,417,897 |
| 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | $822,877 | $10,573,359 |
| 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | $791,228 | $8,837,397 |
| 2021 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | $723,905 | $1,240,821 |
| 2020 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | $673,400 | $10,679,282 |
| 2019 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | $438,258 | $5,236,630 |
| 2018 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | — | — |
Executive changes
Earnings-call appearances
-
Aurinia Pharmaceuticals Inc. Q4 FY2025 Earnings Call2026-02-26
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2025 Earnings Call2025-11-04
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2025 Earnings Call2025-07-31
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2025 Earnings Call2025-06-30
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q4 FY2024 Earnings Call2025-02-27
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2024 Earnings Call2024-11-07
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2024 Earnings Call2024-08-01
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2024 Earnings Call2024-03-31
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q4 FY2023 Earnings Call2024-02-15
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2023 Earnings Call2023-11-02
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2023 Earnings Call2023-08-03
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2023 Earnings Call2023-05-04
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q4 FY2022 Earnings Call2023-02-28
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2022 Earnings Call2022-11-03
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2022 Earnings Call2022-08-04
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2022 Earnings Call2022-05-10
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q4 FY2021 Earnings Call2022-02-28
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2021 Earnings Call2021-11-03
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2021 Earnings Call2021-08-05
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2021 Earnings Call2021-05-06
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q4 FY2020 Earnings Call2020-12-31
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2020 Earnings Call2020-09-30
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2020 Earnings Call2020-06-30
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2020 Earnings Call2020-03-31
Aurinia Pharmaceuticals Inc. (AUPH)